Emirates A380 to become a regular fixture in Muscat

The A380 Amman service was led by Captain Arif Al-Reyami and Jordanian First Officer Laith Saudi.
Updated 03 June 2019

Emirates A380 to become a regular fixture in Muscat

Emirates is gearing up for a big summer in Muscat with the deployment of double daily A380 flights from July 1. The airline will operate the A380 on EK 862/863 and EK864/865 to and from Muscat International Airport. Muscat will become Emirates’ shortest scheduled A380 flight, flying a distance of 340 km each way. 

Sheikh Majid Al-Mualla, divisional senior vice president commercial operations center, said: “The introduction of the A380 services to Muscat means more of our customers will have the opportunity to experience our industry-leading products onboard, and will also enhance choice and travel preferences as they plan their journeys. Oman is an important destination for Emirates, and we will continue to look at ways to grow our operations in the market to best serve our customers.”

He added: “We thank Muscat International Airport and the government authorities for their support in making the A380 double daily operations happen.” 

Sheikh Aimen bin Ahmed Al-Hosni, CEO of Oman Airports, said: “From its side, Muscat International Airport has demonstrated its readiness for this extraordinary event, and the arrival of these scheduled flights for this giant aircraft is a gain to prove the large airport capacity to accommodate an aircraft of this size.” The launch of the A380 flights will come exactly one year after the first deployment of a scheduled one-off A380 service that marked 25 years of operations to Oman.

Both A380s flying to Muscat will be operated in a three-class configuration, with 429 seats in economy class on the lower deck, as well as 76 flat-bed seats in business class and 14 first class private suites on the upper deck. 

Passengers traveling across all three classes will enjoy the airline’s inflight entertainment system, ice, offering more than 4,000 channels of entertainment, and savor regionally inspired meals.

Emirates has been flying to Oman since 1993, and today operates three daily services utilizing the Boeing 777-300ER between Dubai and Muscat, connecting passengers to over 150 global destinations in the Far East, Europe and the US.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.